SCHEMBL5597436

SCHEMBL5597436

COc1cc(NS(=O)(=O)c2ccc(C)cc2)c2ncccc2c1.NCC(N)Cc1ccccn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.71
TDP1 Q9NUW8 6/20 0.71
MEN1 O00255 5/20 0.71
LMNA P02545 2/20 0.71
MAPT P10636 2/20 0.71
AGTR1 P30556 2/20 0.71
NPSR1 Q6W5P4 2/20 0.71
TP53 P04637 1/20 0.71
HPGD P15428 1/20 0.71
TSHR P16473 1/20 0.71
CXCR2 P25025 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
CKS1B P61024 4/20 0.63
SKP2 Q13309 4/20 0.63
SLC40A1 Q9NP59 9/20 0.62
POLB P06746 1/20 0.60
NFKBIA P25963 3/20 0.56
RELA Q04206 2/20 0.56
GLO1 Q04760 2/20 0.49
MITF O75030 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29575795 0.84 KMT2A (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL1505430 0.84 KMT2A (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL7197593 0.78 SLC40A1 (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL13633886 0.78 MEN1 (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL17506531 0.78 CKS1B (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL22076984 0.76 MEN1 (1.00) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL22111633 0.75 MEN1 (0.84) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL4489851 0.75 MEN1 (0.84) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL17506539 0.75 KMT2A (0.79) KMT2ATDP1MEN1LMNAMAPT
SCHEMBL29800829 0.73 GLO1 (0.78) KMT2ATDP1MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275943-A1 Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders ACRUX DDS PTY LTD. 2007-11-29 US claimed
EP-1684761-A1 METHOD AND COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF AMYLOIDOSIS DISORDERS Acrux DDS Pty Ltd (AU) 2006-08-02 EP claimed
WO-2005049026-A1 METHOD AND COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF AMYLOIDOSIS DISORDERS ACRUX DDS PTY LTD (AU) 2005-06-02 WO claimed
WO-2014062424-A1 FLOWABLE FORMULATIONS FOR TISSUE REPAIR AND REGENERATION TISSUE REPAIR COMPANY (US) 2014-04-24 WO disclosed
US-20130096064-A1 FLOWABLE FORMULATIONS FOR TISSUE REPAIR AND REGENERATION TISSUE REPAIR COMPANY (US) 2013-04-18 US disclosed
US-20070275943-A1 Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders ACRUX DDS PTY LTD. 2007-11-29 US disclosed
EP-1684761-A1 METHOD AND COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF AMYLOIDOSIS DISORDERS Acrux DDS Pty Ltd (AU) 2006-08-02 EP disclosed
WO-2005049026-A1 METHOD AND COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF AMYLOIDOSIS DISORDERS ACRUX DDS PTY LTD (AU) 2005-06-02 WO disclosed